NO20054718L - Terapeutisk og/eller preventivt middel for kroniske hudsykdommer - Google Patents
Terapeutisk og/eller preventivt middel for kroniske hudsykdommerInfo
- Publication number
- NO20054718L NO20054718L NO20054718A NO20054718A NO20054718L NO 20054718 L NO20054718 L NO 20054718L NO 20054718 A NO20054718 A NO 20054718A NO 20054718 A NO20054718 A NO 20054718A NO 20054718 L NO20054718 L NO 20054718L
- Authority
- NO
- Norway
- Prior art keywords
- therapeutic
- skin diseases
- chronic skin
- preventative agent
- preventative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003071822 | 2003-03-17 | ||
PCT/JP2004/003554 WO2004082683A1 (ja) | 2003-03-17 | 2004-03-17 | 慢性皮膚疾患の治療および/または予防剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20054718D0 NO20054718D0 (no) | 2005-10-13 |
NO20054718L true NO20054718L (no) | 2005-12-09 |
Family
ID=33027707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20054718A NO20054718L (no) | 2003-03-17 | 2005-10-13 | Terapeutisk og/eller preventivt middel for kroniske hudsykdommer |
Country Status (14)
Country | Link |
---|---|
US (1) | US20060173028A1 (ru) |
EP (1) | EP1621196A4 (ru) |
JP (1) | JPWO2004082683A1 (ru) |
KR (1) | KR20050108402A (ru) |
CN (1) | CN1761466A (ru) |
AU (1) | AU2004222432A1 (ru) |
BR (1) | BRPI0408314A (ru) |
CA (1) | CA2519026A1 (ru) |
HR (1) | HRP20050905A2 (ru) |
MX (1) | MXPA05009921A (ru) |
NO (1) | NO20054718L (ru) |
RU (1) | RU2005131943A (ru) |
WO (1) | WO2004082683A1 (ru) |
ZA (1) | ZA200507497B (ru) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2006098353A1 (ja) * | 2005-03-15 | 2008-08-28 | 協和醗酵工業株式会社 | 外用剤 |
WO2006123726A1 (ja) * | 2005-05-18 | 2006-11-23 | Kyowa Hakko Kogyo Co., Ltd. | 医薬組成物 |
WO2008077404A1 (en) * | 2006-12-22 | 2008-07-03 | Leo Pharma A/S | Substituted acetophenones useful as pde4 inhibitors |
WO2013030789A1 (en) * | 2011-08-30 | 2013-03-07 | Ranbaxy Laboratories Limited | Pharmaceutical oral solid dosage form containing a poorly water soluble pde - iv inhibitor |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT771794E (pt) * | 1995-05-19 | 2006-09-29 | Kyowa Hakko Kogyo Kk | Compostos heterociclicos contendo oxigenio |
US6514996B2 (en) * | 1995-05-19 | 2003-02-04 | Kyowa Hakko Kogyo Co., Ltd. | Derivatives of benzofuran or benzodioxole |
TW555759B (en) * | 1998-06-08 | 2003-10-01 | Darwin Discovery Ltd | Heterocyclic compounds and their therapeutic use |
MY123585A (en) * | 2000-03-23 | 2006-05-31 | Merck Canada Inc | Tri-aryl-substituted-ethane pde4 inhibitors. |
KR20040017246A (ko) * | 2001-06-29 | 2004-02-26 | 니켄 가가쿠 가부시키가이샤 | 사이클로알케논 유도체 |
TWI221838B (en) * | 2001-08-09 | 2004-10-11 | Tanabe Seiyaku Co | Pyrazinoisoquinoline compound or naphthalene compound |
DE10205274A1 (de) * | 2002-02-08 | 2003-08-21 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen enthaltend neben Anticholinergika heterocyclische Verbindungen |
JPWO2006098353A1 (ja) * | 2005-03-15 | 2008-08-28 | 協和醗酵工業株式会社 | 外用剤 |
-
2004
- 2004-03-17 WO PCT/JP2004/003554 patent/WO2004082683A1/ja not_active Application Discontinuation
- 2004-03-17 CA CA002519026A patent/CA2519026A1/en not_active Abandoned
- 2004-03-17 MX MXPA05009921A patent/MXPA05009921A/es not_active Application Discontinuation
- 2004-03-17 US US10/548,639 patent/US20060173028A1/en not_active Abandoned
- 2004-03-17 RU RU2005131943/15A patent/RU2005131943A/ru not_active Application Discontinuation
- 2004-03-17 JP JP2005503713A patent/JPWO2004082683A1/ja not_active Abandoned
- 2004-03-17 EP EP04721318A patent/EP1621196A4/en not_active Withdrawn
- 2004-03-17 BR BRPI0408314-8A patent/BRPI0408314A/pt not_active IP Right Cessation
- 2004-03-17 AU AU2004222432A patent/AU2004222432A1/en not_active Abandoned
- 2004-03-17 KR KR1020057017352A patent/KR20050108402A/ko not_active Application Discontinuation
- 2004-03-17 CN CNA2004800071355A patent/CN1761466A/zh active Pending
-
2005
- 2005-09-16 ZA ZA200507497A patent/ZA200507497B/en unknown
- 2005-10-13 NO NO20054718A patent/NO20054718L/no not_active Application Discontinuation
- 2005-10-17 HR HR20050905A patent/HRP20050905A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20060173028A1 (en) | 2006-08-03 |
HRP20050905A2 (hr) | 2006-04-30 |
RU2005131943A (ru) | 2006-03-20 |
CA2519026A1 (en) | 2004-09-30 |
EP1621196A4 (en) | 2007-03-21 |
JPWO2004082683A1 (ja) | 2006-06-22 |
AU2004222432A1 (en) | 2004-09-30 |
BRPI0408314A (pt) | 2006-03-07 |
KR20050108402A (ko) | 2005-11-16 |
WO2004082683A1 (ja) | 2004-09-30 |
MXPA05009921A (es) | 2005-11-04 |
CN1761466A (zh) | 2006-04-19 |
NO20054718D0 (no) | 2005-10-13 |
ZA200507497B (en) | 2007-02-28 |
EP1621196A1 (en) | 2006-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI9630U1 (fi) | Järjestelmä potilaan silmän verkkokalvon hoitamiseksi laserilla | |
NO20050060L (no) | Medikament for behandling av overaktiv blaere | |
NO20053126D0 (no) | Kontrollsystem for medisinsk behandling. | |
NO20070046L (no) | Nytt cykloheksanderivat, prodrug derav og salt derav, og terapeutisk middel inneholdende de samme for diabetes | |
DK1690550T3 (da) | Terapeutisk middel til mesothelioma | |
UY26372A1 (es) | "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen " | |
AR049876A1 (es) | Composiciones farmaceuticas para tratar enfermedades de la piel que comprenden una combinacion de epinastina y uno o mas minerales adicionales o uno o mas farmacos brutos | |
DK1814848T3 (da) | 2,3,4-substitueret-cyclopentanoner som terapeutiske midler | |
UY27455A1 (es) | Derivados n-(1,4,5,6-tetrahidro-ciclopentapirazol -3-il)- sustituidos. su obtención y uso como fármacos. | |
AU2002226690A1 (en) | Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases | |
FR2864958B1 (fr) | Derive de n-[(1,5-diphenyl-1h-pyrazol-3-yl)methyl] sulfonamide, leur preparation et leur application en therapeutique. | |
ITRM20010476A0 (it) | Lamine di epitelio corneale umano ricostruite e metodo per il loro ottenimento. | |
NO20054718L (no) | Terapeutisk og/eller preventivt middel for kroniske hudsykdommer | |
JP2005511619A5 (ru) | ||
DK1138306T3 (da) | Medicinsk eller dentalmedicinsk behandlingsstol eller en hovedstötte til en sådan behandlingsstol | |
AR032422A1 (es) | Uso de inhibidores de il-18 para el tratamiento y/o prevencion de la enfermedad cardiaca | |
SE0002729D0 (sv) | Novel compound form | |
CY1111608T1 (el) | Σκευασμα φλουπιρτινης για τη θεραπεια νευροεκφυλιστικων νοσων του οπτικου συστηματος και του σακχαρωδη διαβητη | |
NO20054320D0 (no) | Terapeutisk middel mot hemoroidesykdom | |
NO20064196L (no) | Utvortes preparat for behandling av smertefulle hudskader | |
ATE435853T1 (de) | Prostaglandinanaloga | |
HRP20050497B1 (en) | Use of levocetirizine for the persistent allergic rhinitis | |
ITMI20001053A0 (it) | Derivati 2-amminotetralinici otticamente attivi, procedimenti per la loro preparazione e impiego terapeutico delle corrispondenti composizio | |
ES2188232T3 (es) | Uso de cetirizina para impedir la aparicion del asma. | |
NO20032035D0 (no) | Terapeutiske midler for heratokonjunktivitis sykdommer omfattende farnesyleddiksyre som aktiv ingrediens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |